tirabrutinib brand name velexbru drug used treatment autoimmune disorders hematological tirabrutinib approved march japan treatment recurrent refractory primary central nervous system addition tirabrutinib clinical development ono pharmaceutical gilead united states europe japan autoimmune disorders chronic lymphocytic leukemia b cell lymphoma sjogrens syndrome pemphigus rheumatoid tirabrutinib irreversible inhibitor brutons tyrosine httpsenwikipediaorgwikitirabrutinib